Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 945-517-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation, other
- Remarks:
- Points 8.1 and 8.2 of Annex VIII of REACH have been amended. Nevertheless, adequate information from existing in vivo studies can still be used to fulfil the information requirement at any tonnage level.
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From the 5th of December, 1988 to the 5th of January, 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study conducted according to internationally accepted testing guideline
Cross-reference
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Remarks:
- Points 8.1 and 8.2 of Annex VIII of REACH have been amended. Nevertheless, adequate information from existing in vivo studies can still be used to fulfil the information requirement at any tonnage level.
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From the 5th of December, 1988 to the 5th of January, 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Study conducted according to internationally accepted testing guideline
- Justification for type of information:
- Justification for Read Across is detailed in the endpoint summary and it is further detailed in the report attached to the IUCLID section 13.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Principles of method if other than guideline:
- Test conducted according to the publication: "Allergic Contact Dermatitis in the Guinea pig: Identification of Contact Allergens" Mangusson B. Kligman A.M., 1970.
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Points 8.1 and 8.2 of Annex VIII of REACH have been amended. Nevertheless, adequate information from existing in vivo studies can still be used to fulfil the information requirement at any tonnage level.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
Source: Kleintierfarm Madoerin AG
Age at study initiation: (♂) 7 weeks; (♀) 8 weeks
Weight at study initiation: (♂) 416 - 461 g; (♀) 409 - 459 g
Housing: Individually in Makrolon cages type-3 with standard softwood bedding ("Lignocel", Schill AG)
Diet : Ad libitum Pelletted standard Kliba 342, Batch 47/88 guinea pig breeding/ maintenance diet
Water (e.g. ad libitum): Ad libitum community tap water from Itingen
Acclimation period: One week under test conditions after veterinary examination
ENVIRONMENTAL CONDITIONS
Temperature (°C): 22 ± 3 °C
Humidity (%): 40 - 70 %
Air changes (per hr): 10 - 15
Photoperiod (hrs dark/hrs light): 12/12, music during the light period - Route:
- intradermal and epicutaneous
- Vehicle:
- petrolatum
- Concentration / amount:
- PRELIMINARY STUDYIntradermal injection: 0.1, 0.3, 0.5, 1, 3 and 5 % of test article in petrolatum oil (0.1 ml/site)Epidermal application: 3, 5, 10 and 25 % of test article in petrolatum oilMAIN STUDY - INDUCTIONIntradermal injection: - Freunds' complete adjuvant 50:50 with bidistille water- 0.5 % of test article in petrolatum oil (0.1 ml/site)- 0.5 % of test article emulsified in a 50:50 mixture of Freunds complete adjuvant, and petrolatum oilEpidermal Application (1 week after injections): 5 % in petrolatum oilMAIN STUDY - CHALLENGE3 % in petrolatum oil
- Route:
- epicutaneous, occlusive
- Vehicle:
- petrolatum
- Concentration / amount:
- PRELIMINARY STUDYIntradermal injection: 0.1, 0.3, 0.5, 1, 3 and 5 % of test article in petrolatum oil (0.1 ml/site)Epidermal application: 3, 5, 10 and 25 % of test article in petrolatum oilMAIN STUDY - INDUCTIONIntradermal injection: - Freunds' complete adjuvant 50:50 with bidistille water- 0.5 % of test article in petrolatum oil (0.1 ml/site)- 0.5 % of test article emulsified in a 50:50 mixture of Freunds complete adjuvant, and petrolatum oilEpidermal Application (1 week after injections): 5 % in petrolatum oilMAIN STUDY - CHALLENGE3 % in petrolatum oil
- No. of animals per dose:
- PRELIMINARY STUDY
Intradermal injection: 1 animal per sex per dose
Epidermal application: 4 concentrations per animal
MAIN STUDY10 animal per sex per dose - Details on study design:
- PRELIMINARY STUDY
A. INTRADERMAL INJECTION
Concentrations: 0.1, 0.3, 0.5, 1, 3 and 5 % of the test item in petrolatum oil
Exposure period: 24 hours- Volume of injection: 0.1 ml/site
B. EPIDERMAL APPLICATION
Area of exposition: 2 x 2 cm patches of filtred paper satured with petrolatum oil and test item solution
Concentrations: 3, 5 10 and 25 % of the test item in petrolatum oil
Type of coverage: Occlusive, the patches were covered by a strip of aluminium foil and firmly secured by elastic plaster wound round the trunk and covered with impervious adhesive tape.
Exposure time: 24 hours
MAIN STUDYA. INDUCTION EXPOSURE
intradermal injection
No. of exposures: three pairs of intradermal injection
Test groups: 10 male and 10 female
Control group: 5 male and 5 female, omission fo the test article
Site: area of dorsal skin from the scapular region (6 x 8 cm) clipped free of hair
Concentrations: (1) Freunds' complete adjuvant 50:50 with bidistille water; (2) 0.5 % of test article in petrolatum oil (0.1 ml/site); (3) 0.5 % of test article emulsified in a 50:50 mixture of Freunds complete adjuvant, and petrolatum oil
B. INDUCTION EXPOSURE
Epidermal application (1 week after injection)
Area of exposition: 2 x 4 cm patches of filtred paper satured with petrolatum oil and test item solution applied to the scapular area slipped and shaved free of hair (6 x 8 cm)
Concentrations: 5 % of the test item in petrolatum oil
Type of coverage: Occlusive, the patches were covered by a strip of aluminium foil and firmly secured by elastic plaster wound round the trunk and covered with impervious adhesive tape.
Exposure time: 48 hours
Test groups: 10 male and 10 female
Control group: 5 male and 5 female, omission fo the test article
Evaluation of erythema and oedema: immediately, 24 and 48 hours after the removal of the patched
C. CHALLENGE EXPOSURE
2 weeks after the epidermal application)
Area of exposition: two patches (2 x 2 cm) of filtred paper satured with petrolatum oil and test item and with petrolatum oil were applied to the scapular area slipped and shaved free of hair (5 x 5 cm) of each guinea pig.
Exposure period: 24 hours
Test groups: 10 male and 10 female
Control group: 5 male and 5 female, omission fo the test article
Concentrations: 3 % of the test item in petrolatum oil
Evaluation (hr after challenge): immediately, 24 and 48 hours after the removal of the patched - Challenge controls:
- Each Guinea pig were treated with: a) non-irritant concentration (3 % in petrolatum oil) of the test article on the left flankb) vehicle alone on the right flank
- Positive control substance(s):
- yes
- Remarks:
- 1-chloro-2,4-dinitro-benzol (DNCB)
- Positive control results:
- Positive erythema reactions after first challenge procedure: 67 % Strong skin sensitizing potential in the guinea pig strain used
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 0
- Group:
- test chemical
- Dose level:
- 3 % of test article in petrolatum oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- See below
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 0.0. Group: test group. Dose level: 3 % of test article in petrolatum oil. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3 % of test article in petrolatum oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- See below
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 24.0. Group: test group. Dose level: 3 % of test article in petrolatum oil. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3 % of test article in petrolatum oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- See below
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 48.0. Group: test group. Dose level: 3 % of test article in petrolatum oil. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 0
- Group:
- negative control
- Dose level:
- Petrolatum oil alone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- See below
- Remarks on result:
- other: Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 0.0. Group: negative control. Dose level: Petrolatum oil alone. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Petrolatum oil alone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- See below
- Remarks on result:
- other: Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 24.0. Group: negative control. Dose level: Petrolatum oil alone. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Petrolatum oil alone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- See below
- Remarks on result:
- other: Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 48.0. Group: negative control. Dose level: Petrolatum oil alone. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: See below.
- Interpretation of results:
- other: Not classified
- Remarks:
- Classification criteria according to the CLP Regulation 1272/2008 and its amendments
- Conclusions:
- Not sensitising
- Executive summary:
Method
The test has been conducted with the Similar substance 01, according to the GLP procedure and in according to the following guidelines:
OECD Guideline 406, EU Method B.6 and "Allergic Contact Dermatitis in the Guinea pig: Identification of Contact Allergens" Mangusson B. Kligman A.M., 1970 published by C. C. Thomas, Springfiels, Illinois, U.S.A.
Observations
Ten animals (5 per sex) were treated with the vehicle alone (petrolatum oil) and 20 animals (10 per sex) were treated with the test article in petrolatum oil.
No systemic symptoms have been recorded but local symptoms were observed: The animals of the negative control group showed oedema and erythema from day 2 to day 8 on the application area around the injection sites 1, 2 and 3. Necrosis were observed from day 10 to 25 (termination of test).
The animals of the test article-treated group were found to show the same reactions as described above. Additionally discoloration on the treated skin was observed from day 3 to 5 and day 10 to 16.
Nevertheless during the first challenge procedure no positive reactions were evident and no deaths occurred.
Results
The test item does not show any allergenic potential under the test condition.
SENSITIZING EFFECTS
Vehicle control:
No positive reactions were evident after the first challenge application.
Test article:
No positive reactions were evident after the first challenge application.
Due to the unequivocal findings observed after the first challenge, no second challenge was performed.
VIABILITY / MORTALITY
No death occurred
SYMPTOMS, LOCAL
Vehicle control:
Application area around the injection sites 1, 2 and 3 were found to show edema and erythema from day 2 to day 8. Necroses were observed from day 10 to 25 (termination of test).
Test Article:
The animals of the test article-treated group were found to show the same reactions as described above. Additionally discoloration on the treated skin was observed from day 3 to 5 and day 10 to 16.
At the day 9 of test no observation could be performed because the animals were treated semi-occlusively.
SYMPTOMS, SYSTEMIC
No systemic simptoms were observed.
BODY WEIGHTS
Animals n. 916, 917, 918 and 927 (♀) were found to show emaciation during acclimatization.
The body weight gain of all other animals was not affected during the test.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Principles of method if other than guideline:
- Test conducted according to the publication: "Allergic Contact Dermatitis in the Guinea pig: Identification of Contact Allergens" Mangusson B. Kligman A.M., 1970.
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Points 8.1 and 8.2 of Annex VIII of REACH have been amended. Nevertheless, adequate information from existing in vivo studies can still be used to fulfil the information requirement at any tonnage level.
Test material
- Reference substance name:
- Similar substance 01 of Acid Brown 314:1
- IUPAC Name:
- Similar substance 01 of Acid Brown 314:1
- Test material form:
- solid: particulate/powder
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
Source: Kleintierfarm Madoerin AG
Age at study initiation: (♂) 7 weeks; (♀) 8 weeks
Weight at study initiation: (♂) 416 - 461 g; (♀) 409 - 459 g
Housing: Individually in Makrolon cages type-3 with standard softwood bedding ("Lignocel", Schill AG)
Diet : Ad libitum Pelletted standard Kliba 342, Batch 47/88 guinea pig breeding/ maintenance diet
Water (e.g. ad libitum): Ad libitum community tap water from Itingen
Acclimation period: One week under test conditions after veterinary examination
ENVIRONMENTAL CONDITIONS
Temperature (°C): 22 ± 3 °C
Humidity (%): 40 - 70 %
Air changes (per hr): 10 - 15
Photoperiod (hrs dark/hrs light): 12/12, music during the light period
Results and discussion
- Positive control results:
- Positive erythema reactions after first challenge procedure: 67 % Strong skin sensitizing potential in the guinea pig strain used
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 0
- Group:
- test chemical
- Dose level:
- 3 % of test article in petrolatum oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- See below
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 0.0. Group: test group. Dose level: 3 % of test article in petrolatum oil. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3 % of test article in petrolatum oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- See below
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 24.0. Group: test group. Dose level: 3 % of test article in petrolatum oil. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3 % of test article in petrolatum oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- See below
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 48.0. Group: test group. Dose level: 3 % of test article in petrolatum oil. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 0
- Group:
- negative control
- Dose level:
- Petrolatum oil alone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- See below
- Remarks on result:
- other: Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 0.0. Group: negative control. Dose level: Petrolatum oil alone. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Petrolatum oil alone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- See below
- Remarks on result:
- other: Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 24.0. Group: negative control. Dose level: Petrolatum oil alone. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: See below.
- Reading:
- other: Skin response after the first challenge procedure
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Petrolatum oil alone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- See below
- Remarks on result:
- other: Reading: other: Skin response after the first challenge procedure. . Hours after challenge: 48.0. Group: negative control. Dose level: Petrolatum oil alone. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: See below.
Any other information on results incl. tables
SENSITIZING EFFECTS
Vehicle control:
No positive reactions were evident after the first challenge application.
Test article:
No positive reactions were evident after the first challenge application.
Due to the unequivocal findings observed after the first challenge, no second challenge was performed.
VIABILITY / MORTALITY
No death occurred
SYMPTOMS, LOCAL
Vehicle control:
Application area around the injection sites 1, 2 and 3 were found to show edema and erythema from day 2 to day 8. Necroses were observed from day 10 to 25 (termination of test).
Test Article:
The animals of the test article-treated group were found to show the same reactions as described above. Additionally discoloration on the treated skin was observed from day 3 to 5 and day 10 to 16.
At the day 9 of test no observation could be performed because the animals were treated semi-occlusively.
SYMPTOMS, SYSTEMIC
No systemic simptoms were observed.
BODY WEIGHTS
Animals n. 916, 917, 918 and 927 (♀) were found to show emaciation during acclimatization.
The body weight gain of all other animals was not affected during the test.
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified
- Remarks:
- Not classified according to the CLP Regulation - Classification criteria according to the CLP Regulation 1272/2008 and its amendments
- Conclusions:
- Not sensitising
- Executive summary:
Method
The test has been conducted in according to the GLP procedure and in according to the following guidelines:
OECD Guideline 406, EU Method B.6 and "Allergic Contact Dermatitis in the Guinea pig: Identification of Contact Allergens" Mangusson B. Kligman A.M., 1970 published by C. C. Thomas, Springfiels, Illinois, U.S.A.
Observations
Ten animals (5 per sex) were treated with the vehicle alone (petrolatum oil) and 20 animals (10 per sex) were treated with the test article in petrolatum oil.
No systemic symptoms have been recorded but local symptoms were observed: The animals of the negative control group showed oedema and erythema from day 2 to day 8 on the application area around the injection sites 1, 2 and 3. Necrosis were observed from day 10 to 25 (termination of test).
The animals of the test article-treated group were found to show the same reactions as described above. Additionally discoloration on the treated skin was observed from day 3 to 5 and day 10 to 16.
Nevertheless during the first challenge procedure no positive reactions were evident and no deaths occurred.
Results
The test item does not show any allergenic potential under the test condition.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.